CCCC
C4 Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$3.76
+0.53%Leverage
- Debt / equity
- 0.23x
- Net debt / equity
- -0.09x
- Debt / assets
- 0.16x
- Debt / EBITDA
- -0.58x
- Net debt / EBITDA
- 0.22x
Liquidity & coverage
- Current ratio
- 5.45x
- Quick ratio
- 5.45x
- Cash ratio
- 5.26x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $214.7M
Cash & dividend
- FCF / debt
- -1.50x
- Cash flow / debt
- -1.49x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026